Geno.Me is a data exchange platform that links a person’s genetic report with their electronic health records.
Geno.Me has raised $2.2M in total funding. The most recent round was Seed. The last funding was announced in October 2022.
Geno.Me's investors include Gateway Capital Partners.
Geno.Me is headquartered in Madison, United States.
Geno.Me is a data exchange platform that links a person’s genetic report with their electronic health records.
Geno.Me is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Geno.Me — Funding & Investors." VCBacked, October 12, 2022, https://www.vcbacked.co/company/genome. Accessed September 30, 2026.
VCBacked. (2022). Geno.Me — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/genome
{{cite web |title=Geno.Me — Funding & Investors |url=https://www.vcbacked.co/company/genome |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated